-
2
-
-
0027197062
-
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
-
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-1316
-
(1993)
N Engl J Med
, vol.328
, pp. 1313-1316
-
-
Giardiello, F.M.1
Hamilton, S.R.2
Krush, A.J.3
Piantadosi, S.4
Hylind, L.M.5
Celano, P.6
Booker, S.V.7
Robinson, C.R.8
Offerhaus, G.J.9
-
3
-
-
0037018508
-
Primary chemoprevention of familial adenomatous polyposis with sulindac
-
Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, Offerhaus GJ, Hamilton SR. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 2002; 346: 1054-1059
-
(2002)
N Engl J Med
, vol.346
, pp. 1054-1059
-
-
Giardiello, F.M.1
Yang, V.W.2
Hylind, L.M.3
Krush, A.J.4
Petersen, G.M.5
Trimbath, J.D.6
Piantadosi, S.7
Garrett, E.8
Geiman, D.E.9
Hubbard, W.10
Offerhaus, G.J.11
Hamilton, S.R.12
-
4
-
-
17744418769
-
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
-
Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-1952
-
(2000)
N Engl J Med
, vol.342
, pp. 1946-1952
-
-
Steinbach, G.1
Lynch, P.M.2
Phillips, R.K.3
Wallace, M.H.4
Hawk, E.5
Gordon, G.B.6
Wakabayashi, N.7
Saunders, B.8
Shen, Y.9
Fujimura, T.10
Su, L.K.11
Levin, B.12
-
5
-
-
0027141503
-
Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
-
Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 1618-1619
-
(1993)
Br J Surg
, vol.80
, pp. 1618-1619
-
-
Nugent, K.P.1
Farmer, K.C.2
Spigelman, A.D.3
Williams, C.B.4
Phillips, R.K.5
-
6
-
-
0025834849
-
Sulindac causes regression of rectal polyps in familial adenomatous polyposis
-
Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-639
-
(1991)
Gastroenterology
, vol.101
, pp. 635-639
-
-
Labayle, D.1
Fischer, D.2
Vielh, P.3
Drouhin, F.4
Pariente, A.5
Bories, C.6
Duhamel, O.7
Trousset, M.8
Attali, P.9
-
7
-
-
0030019753
-
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam
-
Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, Dove WF. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 1996; 56: 710-714
-
(1996)
Cancer Res
, vol.56
, pp. 710-714
-
-
Jacoby, R.F.1
Marshall, D.J.2
Newton, M.A.3
Novakovic, K.4
Tutsch, K.5
Cole, C.E.6
Lubet, R.A.7
Kelloff, G.J.8
Verma, A.9
Moser, A.R.10
Dove, W.F.11
-
8
-
-
0029739519
-
Sulindac suppresses tumorigenesis in the Min mouse
-
Beazer-Barclay Y, Levy DB, Moser AR, Dove WF, Hamilton SR, Vogelstein B, Kinzler KW. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 1996; 17: 1757-1760
-
(1996)
Carcinogenesis
, vol.17
, pp. 1757-1760
-
-
Beazer-Barclay, Y.1
Levy, D.B.2
Moser, A.R.3
Dove, W.F.4
Hamilton, S.R.5
Vogelstein, B.6
Kinzler, K.W.7
-
9
-
-
0034057928
-
The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action
-
Smith ML, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 2000; 36: 664-674
-
(2000)
Eur J Cancer
, vol.36
, pp. 664-674
-
-
Smith, M.L.1
Hawcroft, G.2
Hull, M.A.3
-
10
-
-
0027468941
-
Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
-
Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 9049-9054
-
(1993)
J Biol Chem
, vol.268
, pp. 9049-9054
-
-
Jones, D.A.1
Carlton, D.P.2
McIntyre, T.M.3
Zimmerman, G.A.4
Prescott, S.M.5
-
11
-
-
0032212487
-
Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas
-
Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM, Sugihara K. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res 1998; 58: 4823-4826
-
(1998)
Cancer Res
, vol.58
, pp. 4823-4826
-
-
Fujita, T.1
Matsui, M.2
Takaku, K.3
Uetake, H.4
Ichikawa, W.5
Taketo, M.M.6
Sugihara, K.7
-
12
-
-
0027993458
-
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
-
Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188
-
(1994)
Gastroenterology
, vol.107
, pp. 1183-1188
-
-
Eberhart, C.E.1
Coffey, R.J.2
Radhika, A.3
Giardiello, F.M.4
Ferrenbach, S.5
DuBois, R.N.6
-
13
-
-
0027371123
-
Altered eicosanoid levels in human colon cancer
-
Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122: 518-523
-
(1993)
J Lab Clin Med
, vol.122
, pp. 518-523
-
-
Rigas, B.1
Goldman, I.S.2
Levine, L.3
-
14
-
-
0036006453
-
Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy
-
Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 2002; 8: 289-293
-
(2002)
Nat Med
, vol.8
, pp. 289-293
-
-
Pai, R.1
Soreghan, B.2
Szabo, I.L.3
Pavelka, M.4
Baatar, D.5
Tarnawski, A.S.6
-
15
-
-
0035866401
-
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
-
Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM, Evans JF. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001; 61: 1733-1740
-
(2001)
Cancer Res
, vol.61
, pp. 1733-1740
-
-
Oshima, M.1
Murai, N.2
Kargman, S.3
Arguello, M.4
Luk, P.5
Kwong, E.6
Taketo, M.M.7
Evans, J.F.8
-
16
-
-
0030606299
-
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
-
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809
-
(1996)
Cell
, vol.87
, pp. 803-809
-
-
Oshima, M.1
Dinchuk, J.E.2
Kargman, S.L.3
Oshima, H.4
Hancock, B.5
Kwong, E.6
Trzaskos, J.M.7
Evans, J.F.8
Taketo, M.M.9
-
17
-
-
0034019416
-
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398
-
Elder DJ, Halton DE, Crew TE, Paraskeva C. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer 2000; 86: 553-560
-
(2000)
Int J Cancer
, vol.86
, pp. 553-560
-
-
Elder, D.J.1
Halton, D.E.2
Crew, T.E.3
Paraskeva, C.4
-
18
-
-
0032750920
-
Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
-
Jones MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418-1423
-
(1999)
Nat Med
, vol.5
, pp. 1418-1423
-
-
Jones, M.K.1
Wang, H.2
Peskar, B.M.3
Levin, E.4
Itani, R.M.5
Sarfeh, I.J.6
Tarnawski, A.S.7
-
19
-
-
0029658226
-
Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines
-
Tsuji S, Kawano S, Sawaoka H, Takei Y, Kobayashi I, Nagano K, Fusamoto H, Kamada T. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids 1996; 55: 179-183
-
(1996)
Prostaglandins Leukot Essent Fatty Acids
, vol.55
, pp. 179-183
-
-
Tsuji, S.1
Kawano, S.2
Sawaoka, H.3
Takei, Y.4
Kobayashi, I.5
Nagano, K.6
Fusamoto, H.7
Kamada, T.8
-
20
-
-
0030602860
-
Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
-
Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996; 52: 237-245
-
(1996)
Biochem Pharmacol
, vol.52
, pp. 237-245
-
-
Hanif, R.1
Pittas, A.2
Feng, Y.3
Koutsos, M.I.4
Qiao, L.5
Staiano-Coico, L.6
Shiff, S.I.7
Rigas, B.8
-
21
-
-
0030747817
-
Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
-
Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G, Ritchie J, Burt RW, Ellsworth L, Ahnen DJ, Pamukcu R. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997; 57: 2909-2915
-
(1997)
Cancer Res
, vol.57
, pp. 2909-2915
-
-
Piazza, G.A.1
Alberts, D.S.2
Hixson, L.J.3
Paranka, N.S.4
Li, H.5
Finn, T.6
Bogert, C.7
Guillen, J.M.8
Brendel, K.9
Gross, P.H.10
Sperl, G.11
Ritchie, J.12
Burt, R.W.13
Ellsworth, L.14
Ahnen, D.J.15
Pamukcu, R.16
-
22
-
-
0034671921
-
15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells
-
Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res 2000; 60: 6846-6850
-
(2000)
Cancer Res
, vol.60
, pp. 6846-6850
-
-
Shureiqi, I.1
Chen, D.2
Lotan, R.3
Yang, P.4
Newman, R.A.5
Fischer, S.M.6
Lippman, S.M.7
-
23
-
-
0033578879
-
Sulindac inhibits activation of the NF-kappaB pathway
-
Yamamoto Y, Yin MJ, Lin KM, Gaynor RB. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 1999; 274: 27307-27314
-
(1999)
J Biol Chem
, vol.274
, pp. 27307-27314
-
-
Yamamoto, Y.1
Yin, M.J.2
Lin, K.M.3
Gaynor, R.B.4
-
24
-
-
0033615352
-
PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
-
He TC, Chan TA, Vogelstein B, Kinzler KW. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999; 99: 335-345
-
(1999)
Cell
, vol.99
, pp. 335-345
-
-
He, T.C.1
Chan, T.A.2
Vogelstein, B.3
Kinzler, K.W.4
-
25
-
-
0034616946
-
Apoptotic pathways: Paper wraps stone blunts scissors
-
Green DR. Apoptotic pathways: paper wraps stone blunts scissors. Cell 2000; 102: 1-4
-
(2000)
Cell
, vol.102
, pp. 1-4
-
-
Green, D.R.1
-
27
-
-
0032575750
-
Caspases: Enemies within
-
Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-1316
-
(1998)
Science
, vol.281
, pp. 1312-1316
-
-
Thornberry, N.A.1
Lazebnik, Y.2
-
29
-
-
0032575714
-
Death receptors: Signaling and modulation
-
Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308
-
(1998)
Science
, vol.281
, pp. 1305-1308
-
-
Ashkenazi, A.1
Dixit, V.M.2
-
30
-
-
0030954209
-
The CARD domain: A new apoptotic signalling motif
-
Hofmann K, Bucher P, Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci 1997; 22: 155-156
-
(1997)
Trends Biochem Sci
, vol.22
, pp. 155-156
-
-
Hofmann, K.1
Bucher, P.2
Tschopp, J.3
-
31
-
-
0037311226
-
Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines
-
Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res 2003; 63: 621-626
-
(2003)
Cancer Res
, vol.63
, pp. 621-626
-
-
Kim, D.M.1
Koo, S.Y.2
Jeon, K.3
Kim, M.H.4
Lee, J.5
Hong, C.Y.6
Jeong, S.7
-
32
-
-
0242691851
-
Enhanced apoptosis of ghoma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector
-
Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY. Enhanced apoptosis of ghoma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Cancer Gene Ther 2003; 10: 814-822
-
(2003)
Cancer Gene Ther
, vol.10
, pp. 814-822
-
-
Rubinchik, S.1
Yu, H.2
Woraratanadharm, J.3
Voelkel-Johnson, C.4
Norris, J.S.5
Dong, J.Y.6
-
33
-
-
0141705424
-
Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo
-
Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res 2003; 63: 5390-5400
-
(2003)
Cancer Res
, vol.63
, pp. 5390-5400
-
-
Singh, T.R.1
Shankar, S.2
Chen, X.3
Asim, M.4
Srivastava, R.K.5
-
34
-
-
0037108712
-
Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice
-
Naka T, Sugamura K, Hylander BL, Widmer MB, Rustum YM, Repasky EA. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res 2002; 62: 5800-5806
-
(2002)
Cancer Res
, vol.62
, pp. 5800-5806
-
-
Naka, T.1
Sugamura, K.2
Hylander, B.L.3
Widmer, M.B.4
Rustum, Y.M.5
Repasky, E.A.6
-
35
-
-
0034068601
-
Mitochondrial control of cell death
-
Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000; 6: 513-519
-
(2000)
Nat Med
, vol.6
, pp. 513-519
-
-
Kroemer, G.1
Reed, J.C.2
-
36
-
-
0032575752
-
Mitochondria and apoptosis
-
Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312
-
(1998)
Science
, vol.281
, pp. 1309-1312
-
-
Green, D.R.1
Reed, J.C.2
-
37
-
-
0030773136
-
Implication of mitochondria in apoptosis
-
Petit PX, Zamzami N, Vayssiere JL, Mignotte B, Kroemer G, Castedo M. Implication of mitochondria in apoptosis. Mol Cell Biochem 1997; 174: 185-188
-
(1997)
Mol Cell Biochem
, vol.174
, pp. 185-188
-
-
Petit, P.X.1
Zamzami, N.2
Vayssiere, J.L.3
Mignotte, B.4
Kroemer, G.5
Castedo, M.6
-
38
-
-
0034921727
-
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs
-
REVIEWS3009
-
Verhagen AM, Coulson EJ, Vaux DL. Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2001; 2: REVIEWS3009
-
(2001)
Genome Biol
, vol.2
-
-
Verhagen, A.M.1
Coulson, E.J.2
Vaux, D.L.3
-
39
-
-
0034597630
-
ML-LAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
-
Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM. ML-LAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000; 10: 1359-1366
-
(2000)
Curr Biol
, vol.10
, pp. 1359-1366
-
-
Vucic, D.1
Stennicke, H.R.2
Pisabarro, M.T.3
Salvesen, G.S.4
Dixit, V.M.5
|